Hennessy Advisors Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-173,500
Closed -$9.22M 289
2020
Q3
$9.22M Sell
173,500
-11,400
-6% -$679K 0.64% 49
2020
Q2
$10.8M Sell
184,900
-15,200
-8% -$817K 0.75% 33
2020
Q1
$7.89M Sell
200,100
-69,200
-26% -$4.05M 0.59% 42
2019
Q4
$16M Buy
269,300
+215,200
+398% +$11.6M 0.82% 22
2019
Q3
$2.88M Sell
54,100
-1,300
-2% -$66.7K 0.14% 175
2019
Q2
$2.83M Buy
+55,400
New +$2.58M 0.14% 189

Other funds holding SYNH

Hennessy Advisors Inc's SYNH Position: Q4 2020 in Review

Hennessy Advisors Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 173,500 shares — an estimated $9.22M sold.

Hennessy Advisors Inc first reported a position in SYNH in Q2 2019 and held it in 6 quarters. The position peaked at $16M in Q4 2019. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

  • Hennessy Advisors Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Hennessy Advisors Inc sold 173,500 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $9.22M.
  • Hennessy Advisors Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 6 quarters.
  • Hennessy Advisors Inc's Syneos Health, Inc. Class A Common Stock position peaked at $16M in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Hennessy Advisors Inc's 13F filing for Q4 2020, filed 25 Jan 2021.